These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4872105)

  • 1. [Biochemical study of inhibition of ovarian function with ethinodiol diacetate].
    Geller S
    Pathol Biol; 1968 Mar; 16(5):347-52. PubMed ID: 4872105
    [No Abstract]   [Full Text] [Related]  

  • 2. The ovarian response to gonadotrophins after administration of an oral contraceptive.
    Pujol-Amat P; Urgell-Roca JM; Mároquez-Ramirez M
    J Obstet Gynaecol Br Commonw; 1971 Mar; 78(3):261-5. PubMed ID: 5558842
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of ovarian biopsies from women cyclically treated with the combination ethynodiol diacetate+mestranol alone and together with human menopausal gonadotrophin (Pergonal)+HCG.
    Pujol-Amat P; Urgell-Roca JM; Esteban-Altirriba J; Márquez-Ramirez M
    Gynaecologia; 1969; 167(4):237-49. PubMed ID: 5767877
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study with 1 mg of ethynodiol diacetate and 0.1 mg (1.0-0.1) mestranol].
    Mateos Candano M; Bolio Arista R
    Ginecol Obstet Mex; 1967; 22(127):151-61. PubMed ID: 5604500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colposcopic study of the cervix uteri during the administration of ethynodiol diacetate with mestranol].
    Carbia Aguilar E; Alvarado Duran A; Lopez Llera M
    Ginecol Obstet Mex; 1968 Mar; 23(137):377-85. PubMed ID: 5674336
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
    Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
    Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
    [No Abstract]   [Full Text] [Related]  

  • 7. [Temporary control of fertility with ethynodiol diacetate and mestranol (1.0/0.1) in women with a high obstetrical risk. Study of 2400 cycles].
    Alvarado Duran A; Lopez Llera M; Carbia Aguilar E
    Ginecol Obstet Mex; 1968 Feb; 23(136):291-300. PubMed ID: 5681098
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postpartal continuous administration of ethinodiol diacetate as a contraceptive agent].
    Friedrich F; Golob E
    Geburtshilfe Frauenheilkd; 1973 Apr; 33(4):310-4. PubMed ID: 4541167
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of ovulation time with steroid and nonsteroid compounds.
    Boutselis JG; Dickey RP; Vorys N
    Am J Obstet Gynecol; 1972 Jan; 112(2):171-7. PubMed ID: 4333405
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraception started early in the puerperium. A clinical study.
    Frank R; Alpern WM; Eshbaugh DE
    Am J Obstet Gynecol; 1969 Jan; 103(1):112-20. PubMed ID: 5812458
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of ethynodiol diacetate and mestranol on blood glucose and plasma insulin. I. Six month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Int J Fertil; 1971; 16(2):55-65. PubMed ID: 5092534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological inhibition of ovulation].
    Haller J
    Fortschr Geburtshilfe Gynakol (1950); 1965; 21():37-106. PubMed ID: 12255694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary effects of ethynodiol diacetate plus mestranol].
    Sánchez L; Lucena E
    Rev Colomb Obstet Ginecol; 1969; 20(4):257-65. PubMed ID: 5356118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The suppression of lactation by FH O27].
    Nimsgern R; Weil A; Diringer A
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(1):81-2. PubMed ID: 5685134
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of ovarian function by stimulation with gonadotrophins.
    Timonen S; Kaivola S
    Ann Chir Gynaecol Fenn; 1968; 57(4):425-30. PubMed ID: 5731311
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum insulin and growth hormone responses to arginine infusion before and during treatment with contraceptive steroids.
    Vela P; Yen SS
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1212-6. PubMed ID: 5817638
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal study of the effects of oral contraceptives on human chromosomes.
    de Gutiérrez AC; Lisker R
    Ann Genet; 1973 Dec; 16(4):259-62. PubMed ID: 4544089
    [No Abstract]   [Full Text] [Related]  

  • 18. [Investigations of the cervical factor in the treatment with Ovulen].
    Odeblad E
    Lakartidningen; 1967 Jul; 64(29):2903-6. PubMed ID: 5597595
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic function in subjects treated with estro-progestinic drugs].
    Scalzerle V; Laudanna Sclazerle A
    Minerva Ginecol; 1968 Feb; 20(4):371-4. PubMed ID: 5738735
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of different synthetic estrogens and gestogens on the human ovary].
    Sanchez De Rivera G; Gonzalez Merlo J; Nogales F; Escuderos M; Botella Llusia J
    Rev Chil Obstet Ginecol; 1967; 32(1):22-9. PubMed ID: 5600662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.